Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. CYTB323A12101

   Novartis Pharmaceuticals

   High-Risk large B-Cell lymphoma, Chronic lymphocytic leukemia/Small lymphocytic lymphoma, Diffuse large B-Cell lymphoma, Acute lymphoblastic leukemia

   phase 2 · small molecule · active

   1 trial →

2. Cabozantinib

   Takeda

   Advanced Hepatocellular Carcinoma

   phase 2 · small molecule · completed

   1 trial →

3. Cabozantinib

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Hepatocellular Carcinoma (HCC)

   phase 2 · small molecule · active

   1 trial →

4. Cabozantinib

   Takeda

   Advanced Renal Cell Carcinoma

   phase 2 · small molecule · completed

   1 trial →

5. Cadonilimab

   The First People's Hospital of Lianyungang

   Lung Cancer

   phase 2 · small molecule · active

   1 trial →

6. Cadonilimab

   The First People's Hospital of Lianyungang

   Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

   phase 2 · small molecule · active

   1 trial →

7. Cadonilimab

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Cervical Cancer

   phase 2 · small molecule · active

   1 trial →

8. Calcio levofolinato Teva Generics polvere per...

   Fondazione Telethon ETS

   Patients with metastatic colorectal cancer (mCRC) RAS-mutant

   phase 2 · small molecule · active

   1 trial →

9. Calquence 100 mg film-coated tablets

   AstraZeneca

   mantle cell lymphoma (MCL)

   phase 2 · small molecule · active

   1 trial →

10. Camidanlumab Tesirine

    ADC Therapeutics SA

    Relapsed Hodgkin Lymphoma

    phase 2 · small molecule · completed

    1 trial →

11. Camrelizumab

    The First People's Hospital of Lianyungang

    Lung Neoplasms

    phase 2 · small molecule · active

    1 trial →

12. Camrelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cervical Cancer

    phase 2 · small molecule · active

    1 trial →

13. Camrelizumab

    The First People's Hospital of Lianyungang

    Locally Advanced or Metastatic Gastric Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

14. Camrelizumab

    The First People's Hospital of Lianyungang

    Lung Cancer, Nonsmall Cell

    phase 2 · small molecule · active

    1 trial →

15. Camrelizumab

    The First People's Hospital of Lianyungang

    Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

16. Camrelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Adrenal Cortical Carcinoma

    phase 2 · small molecule · active

    1 trial →

17. Camrelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 2 · small molecule · active

    1 trial →

18. Camrelizumab

    The First People's Hospital of Lianyungang

    Gastric Cancer Stage III

    phase 2 · small molecule · active

    1 trial →

19. Camrelizumab

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 2 · small molecule · active

    1 trial →

20. Camrelizumab

    The First People's Hospital of Lianyungang

    Melanoma

    phase 2 · small molecule · active

    1 trial →

21. Camrelizumab Plus Apatinib

    Nanjing Zenshine Pharmaceuticals

    Unresectable Hepatocellular Carcinoma (HCC)

    phase 2 · small molecule · active

    1 trial →

22. Camrelizumab and SBRT

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head and Neck Squamous Cell Carcinoma

    phase 2 · other · active

    1 trial →

23. Camrelizumab plus apatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 2 · small molecule · active

    1 trial →

24. Camrelizumab with vinorelbine and cisplatin

    The First People's Hospital of Lianyungang

    HER2-negative Breast Cancer

    phase 2 · small molecule · active

    1 trial →

25. Cangpo Liujun Prescription

    The First People's Hospital of Lianyungang

    Cancer-Related Fatigue

    phase 2 · small molecule · active

    1 trial →

26. Capecitabine

    xie congying

    Gastric Cancer

    phase 2 · small molecule · completed

    1 trial →

27. Capecitabine

    The University of Hong Kong

    Pancreatic Adenocarcinoma

    phase 2 · small molecule · completed

    1 trial →

28. Capecitabine

    Vera Therapeutics

    Breast Cancer

    phase 2 · small molecule · terminated

    1 trial →

29. Capecitabine

    Novartis Pharmaceuticals

    Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

30. Capecitabine

    The First People's Hospital of Lianyungang

    Biliary Carcinoma

    phase 2 · small molecule · active

    1 trial →

31. Capecitabine

    PUMA BIOTECHNOLOGY, INC.

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

32. Capecitabine

    Regeneron UK Limited

    Colorectal Cancer Metastatic

    phase 2 · small molecule · terminated

    1 trial →

33. Capecitabine Accord 500 mg film-coated tablets

    Ningbo Cancer Hospital

    Biliary tract cancer

    phase 2 · small molecule · active

    1 trial →

34. Capecitabine+Cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stomach Neoplasms

    phase 2 · small molecule · terminated

    1 trial →

35. Capecitabine-Oxaliplatin-Irinotecan Combination

    The First People's Hospital of Lianyungang

    Unresectable Metastatic Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

36. Carboplatin

    Children's Hospital of Fudan University

    Central Nervous System Nongerminomatous Germ Cell Tumor

    phase 2 · small molecule · completed

    1 trial →

37. Carboplatin

    United Therapeutics Europe Ltd

    Recurrent Fallopian Tube Carcinoma

    phase 2 · small molecule · active

    1 trial →

38. Carboplatin

    Atrium Therapeutics

    Lung Cancer Stage II

    phase 2 · small molecule · active

    1 trial →

39. Carboplatin

    United Therapeutics Europe Ltd

    Hormone Refractory Prostate Cancer

    phase 2 · small molecule · active

    1 trial →

40. Carboplatin

    Teva Pharma GmbH

    Prostatic Neoplasm

    phase 2 · small molecule · terminated

    1 trial →

41. Carboplatin plus Paclitaxel

    United Therapeutics Europe Ltd

    Ovarian Cancer

    phase 2 · small molecule · active

    1 trial →

42. Casdatifan

    Arcus Biosciences

    Renal Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

43. Casdozokitug

    Coherus Oncology

    Hepatocellular Carcinoma

    phase 2 · small molecule · active

    1 trial →

44. Cediranib

    United Therapeutics Europe Ltd

    Alveolar Soft-part Sarcoma

    phase 2 · small molecule · active

    1 trial →

45. Celecoxib

    United Therapeutics Europe Ltd

    Head and Neck Cancer

    phase 2 · small molecule · terminated

    1 trial →

46. Celecoxib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oral Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

47. Cemiplimab

    Regeneron UK Limited

    Colon and Rectal Cancer

    phase 2 · small molecule · active

    1 trial →

48. Cemiplimab

    Regeneron UK Limited

    Lung Cancer (NSCLC)

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions